Join us in Atlanta next month for this conference about cancer health disparities in racial and ethnic minorities and the medically underserved.
AACR Congratulates Past President Dr. Carlos Arteaga on Appointment as Director of Simmons Comprehensive Cancer Center at UT Southwestern
Philadelphia Marathon Announces New Title Partner
Liquid Biopsies Find Distinct Genomic Profiles in Most Patients with Carcinoma of Unknown Primary
Periodontal Disease is Associated with Higher Risk of Several Cancer Types
Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference, Sept. 6-9, 2017
Conference on The Science of Cancer Health Disparities, Sept. 25-28, 2017
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics, Oct. 26-30, 2017
San Antonio Breast Cancer Symposium, Dec. 5-9, 2017
This Cancer Research Catalyst blog post discusses the FDA approval of enasidenib (Idhifa) and Vyxeos for the treatment of certain groups of patients with acute myeloid leukemia.
Oncology Times covers the recent Turning the Tide conference in Washington, D.C., co-hosted by the AACR.